Literature DB >> 14715442

Involvement of nitric oxide on kainate-induced toxicity in oligodendrocyte precursors.

Laura Martinez-Palma1, Mariana Pehar, Patricia Cassina, Hugo Peluffo, Raquel Castellanos, Gabriel Anesetti, Joseph S Beckman, Luis Barbeito.   

Abstract

The vulnerability of oligodendrocytes to excitatory amino acids may account for the pathology of white matter occurring following hypoxia/ischemia or autoimmune attack. Here, we examined the vulnerability of immature oligodendrocytes (positively labeled by galactocerobroside-C and not expressing myelin basic protein) from neonatal rat spinal cord to kainate, an agonist of excitatory amino acid receptors that induces long-lasting inward currents in immature oligodendrocytes. In particular, we studied whether kainate toxicity was linked to the endogenous production of nitric oxide. We found cultured oligodendrocytes to be highly sensitive to 24-48 h exposure to 0.5-1 mM kainate. The toxin induced striking morphological changes in oligodendrocytes, characterized by the disruption of the process network around the cell body and the growth of one or two long, thick and non-branched processes. A longer exposure to kainate resulted in massive death of oligodendrocytes, which was prevented by 6,7, dinitroquinoxaline-2,3-dione (DNQX) (30 micro M), the antagonist of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic/kainate receptors. Remarkably, we found that those oligodendrocytes displaying bipolar morphology following kainate exposure, also expressed the inducible form of nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity, suggesting that peroxynitrite could be formed by the reaction of nitric oxide with superoxide. Moreover, kainate toxicity was significantly prevented by addition of the NOS inhibitor nitro-L-arginine methyl ester (L-NAME), further suggesting that nitric oxide-derived oxidants contribute to excitotoxic mechanisms in immature oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715442     DOI: 10.1007/bf03033168

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  27 in total

1.  Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity.

Authors:  Paul A Rosenberg; Weimin Dai; Xiao Dong Gan; Sanjida Ali; Jennifer Fu; Stephen A Back; Russell M Sanchez; Michael M Segal; Pamela L Follett; Frances E Jensen; Joseph J Volpe
Journal:  J Neurosci Res       Date:  2003-01-15       Impact factor: 4.164

2.  Extensive peroxynitrite activity during progressive stages of central nervous system inflammation.

Authors:  R C van der Veen; D R Hinton; F Incardonna; F M Hofman
Journal:  J Neuroimmunol       Date:  1997-07       Impact factor: 3.478

3.  Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat.

Authors:  L J Forman; P Liu; R G Nagele; K Yin; P Y Wong
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region.

Authors:  N Fukuyama; S Takizawa; H Ishida; K Hoshiai; Y Shinohara; H Nakazawa
Journal:  J Cereb Blood Flow Metab       Date:  1998-02       Impact factor: 6.200

5.  Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

Authors:  D C Hooper; G S Scott; A Zborek; T Mikheeva; R B Kean; H Koprowski; S V Spitsin
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

6.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination.

Authors:  A H Cross; P T Manning; M K Stern; T P Misko
Journal:  J Neuroimmunol       Date:  1997-12       Impact factor: 3.478

7.  White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism.

Authors:  G K Kanellopoulos; X M Xu; C Y Hsu; X Lu; T M Sundt; N T Kouchoukos
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

8.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.

Authors:  H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

Review 9.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

Review 10.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

View more
  7 in total

1.  Low doses of domoic acid during postnatal development produce permanent changes in rat behaviour and hippocampal morphology.

Authors:  T A Doucette; P B Bernard; H Husum; M A Perry; C L Ryan; R A Tasker
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Pathogenesis of cerebral white matter injury of prematurity.

Authors:  O Khwaja; J J Volpe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-03       Impact factor: 5.747

4.  Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.

Authors:  Jin-Koo Lee; Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  Neurosci Lett       Date:  2008-06-06       Impact factor: 3.046

5.  Selective fluorescent imaging of superoxide in vivo using ethidium-based probes.

Authors:  Kristine M Robinson; Michael S Janes; Mariana Pehar; Jeffrey S Monette; Meredith F Ross; Tory M Hagen; Michael P Murphy; Joseph S Beckman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

Review 6.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

Review 7.  C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.

Authors:  Giselle Pentón-Rol; Javier Marín-Prida; Viviana Falcón-Cama
Journal:  Behav Sci (Basel)       Date:  2018-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.